Background Overall survival rates are disappointing for women with early poor prognosis
breast cancer. Autologous transplantation of bone marrow or peripheral stem cells (in which …

Introduction: High-dose chemotherapy (HDC) with autologous hematopoietic progenitor cell
transplantation (AHPCT) for high-risk (HR) or metastatic breast cancer (MBC) is no longer an …

Background: The efficacy of high-dose chemotherapy (HDC) and autologous hematopoietic
stem cell transplantation for breast cancer (BC) has been an area of intense controversy …

The aim of this retrospective study was to assess toxicity and efficacy of adjuvant high-dose
chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (AHSCT) in …

The efficacy of high-dose chemotherapy (HDC) and autologous hemopoietic progenitor cell
transplantation (AHPCT) for breast cancer (BC) patients has been an area of intense …

Chronic graft-versus-host disease (GVHD) is the leading cause of late, nonrelapse mortality
and disability in allogeneic hematopoietic cell transplantation recipients and a major …

目的: 高复发风险乳腺癌患者术后复发率高. 目前, 对于外周血干细胞移植支持下大剂量化疗在
乳腺癌辅助治疗中的应用价值仍存有争议. 本研究旨在探讨高复发风险乳腺癌患者术后接受外周 …

Simple Summary The initial treatment of early breast cancer has achieved important clinical
results over time. However, late recurrences after many years of disease-free survival …

The problem of late recurrence in breast cancer has recently gained attention and was also
addressed in an international workshop held in Toronto (ON, Canada), in which several …

El cáncer de mama inflamatorio es una patología poco frecuente, sin embargo, su
importancia radica en la agresividad de su evolución. A nivel nacional no existe estadística …